CUVL — Clinuvel Pharmaceuticals Ltd
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1290877 ·
Australia
Last close
$5.63
Market Cap
—
52W High
$8.87
52W Low
$5.60
ADV30
21,283
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 295,091,228 | 252,055,390 | 22,209,933 |
| Jun 2025 | — | — | — | — | 271,750,012 | 224,105,942 | 30,941,386 |
Balance + Analyst (yfinance extras)
Retained Earnings
$63,632,126
Inventory
$8,821,331
Receivables
$27,461,362
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 94,024,398 | 39,546,095 | 33,916,819 | 295,091,228 | 22,209,933 | 272,881,295 | — |
| Jun 2025 | 95,017,570 | 45,733,209 | 36,172,518 | 271,750,012 | 30,941,386 | 240,808,626 | — |
| Jun 2024 | 88,178,308 | 48,005,841 | 35,636,359 | 231,123,549 | 28,112,183 | 203,011,366 | — |
| Jun 2023 | 78,321,318 | 44,102,498 | 30,604,566 | 193,713,556 | 29,082,413 | 164,631,143 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRRN | Bryn Inc. | $945.00B | $2100.00 | — |
| SPY | SPDR S&P 500 ETF TRUST | $707.93B | $771.35 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $249.58B | $675.00 | — |
| KLAC | KLA CORP | $245.53B | $187.92 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $212.46B | $225.51 | — |
News headlines (Yahoo Finance, 1h cache)
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
2026-08-27 05:42 · Yahoo
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
2026-07-23 04:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.